World - Medicaments Of Alkaloids Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingMedicaments Of Alkaloids Or Derivatives Thereof Market
The global market for medicaments of alkaloids or derivatives thereof is projected to see an increase in consumption and production over the next eight years. Key findings include an anticipated CAGR of +2.7% in volume consumption and +4.3% in value terms from 2022 to 2030, reaching 526K tons and $33.9B, respectively, by the end of 2030. Turkey, China, and India lead in consumption, while Turkey, Japan, and Germany lead in production. Hong Kong SAR and New Zealand are major exporters, with prices varying across countries.
Market Forecast
Driven by increasing demand for medicaments of alkaloids or derivatives thereof worldwide, the market is expected to continue an upward consumption trend over the next eight-year period. Market performance is forecast to retain its current trend pattern, expanding with an anticipated CAGR of +2.7% for the period from 2022 to 2030, which is projected to bring the market volume to 526K tons by the end of 2030.
In value terms, the market is forecast to increase with an anticipated CAGR of +4.3% for the period from 2022 to 2030, which is projected to bring the market value to $33.9B (in nominal prices) by the end of 2030.
Consumption
World Consumption of Medicaments Of Alkaloids Or Derivatives Thereof
In 2022, approx. 425K tons of medicaments of alkaloids or derivatives thereof were consumed worldwide; waning by -6.8% on the previous year's figure. Overall, the total consumption indicated a pronounced expansion from 2012 to 2022: its volume increased at an average annual rate of +3.2% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption increased by +9.6% against 2020 indices. Over the period under review, global consumption of hit record highs at 523K tons in 2019; however, from 2020 to 2022, consumption failed to regain momentum.
The value of the market for medicaments of alkaloids or derivatives thereof worldwide dropped to $24.3B in 2022, waning by -5.8% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). In general, consumption, however, continues to indicate measured growth. Over the period under review, the global market hit record highs at $33.9B in 2019; however, from 2020 to 2022, consumption failed to regain momentum.
Consumption By Country
The countries with the highest volumes of consumption in 2022 were Turkey (74K tons), China (68K tons) and India (29K tons), with a combined 40% share of global consumption.
From 2012 to 2022, the biggest increases were recorded for Turkey (with a CAGR of +27.0%), while thereof for the other global leaders experienced more modest paces of growth.
In value terms, the largest medicaments of alkaloids or derivatives thereof markets worldwide were Turkey ($5.1B), Japan ($2.7B) and Germany ($2B), with a combined 41% share of the global market.
Turkey, with a CAGR of +22.7%, saw the highest growth rate of market size in terms of the main consuming countries over the period under review, while thereof for the other global leaders experienced more modest paces of growth.
In 2022, the highest levels of per capita consumption of medicaments of alkaloids or derivatives thereof was registered in Turkey (869 kg per 1000 persons), followed by the UK (153 kg per 1000 persons), France (136 kg per 1000 persons) and Germany (133 kg per 1000 persons), while the world average per capita consumption of medicaments of alkaloids or derivatives thereof was estimated at 54 kg per 1000 persons.
From 2012 to 2022, the average annual rate of growth in terms of the per capita consumption of medicaments of alkaloids or derivatives thereof in Turkey totaled +25.3%. In the other countries, the average annual rates were as follows: the UK (+3.1% per year) and France (+3.2% per year).
Production
World Production of Medicaments Of Alkaloids Or Derivatives Thereof
In 2022, approx. 398K tons of medicaments of alkaloids or derivatives thereof were produced worldwide; dropping by -7.8% on the year before. Over the period under review, the total production indicated a pronounced expansion from 2012 to 2022: its volume increased at an average annual rate of +3.4% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production increased by +9.3% against 2020 indices. The most prominent rate of growth was recorded in 2018 when the production volume increased by 49% against the previous year. Global production peaked at 500K tons in 2019; however, from 2020 to 2022, production remained at a lower figure.
In value terms, production of medicaments of alkaloids or derivatives thereof shrank slightly to $22.4B in 2022 estimated in export price. Overall, production, however, saw pronounced growth. The most prominent rate of growth was recorded in 2019 with an increase of 66% against the previous year. As a result, production attained the peak level of $35.6B. From 2020 to 2022, global production of growth remained at a somewhat lower figure.
Production By Country
The countries with the highest volumes of production in 2022 were Turkey (74K tons), China (68K tons) and India (29K tons), with a combined 43% share of global production.
From 2012 to 2022, the most notable rate of growth in terms of thereof, amongst the key producing countries, was attained by Turkey (with a CAGR of +27.3%), while thereof for the other global leaders experienced more modest paces of growth.
Imports
World Imports of Medicaments Of Alkaloids Or Derivatives Thereof
In 2022, overseas purchases of medicaments of alkaloids or derivatives thereof were finally on the rise to reach 32K tons for the first time since 2019, thus ending a two-year declining trend. Overall, imports, however, showed a abrupt descent. The most prominent rate of growth was recorded in 2016 with an increase of 9% against the previous year. Global imports peaked at 77K tons in 2012; however, from 2013 to 2022, imports remained at a lower figure.
In value terms, imports of medicaments of alkaloids or derivatives thereof rose to $1.7B in 2022. Over the period under review, imports, however, recorded a abrupt contraction. The pace of growth appeared the most rapid in 2018 when imports increased by 9.7%. Over the period under review, global imports of hit record highs at $6.7B in 2012; however, from 2013 to 2022, imports failed to regain momentum.
Imports By Country
Japan (3.3K tons), Canada (3.2K tons), Australia (2.4K tons), Nigeria (2.2K tons), South Korea (2.2K tons), the UK (1.5K tons), Iran (1.5K tons), Malaysia (1.4K tons), Lebanon (1.1K tons), Ukraine (0.8K tons), Kuwait (0.6K tons) and Democratic Republic of the Congo (0.6K tons) represented roughly 65% of total imports in 2022. Zimbabwe (583 tons) took a relatively small share of total imports.
From 2012 to 2022, the biggest increases were recorded for Lebanon (with a CAGR of +25.4%), while purchases for the other global leaders experienced more modest paces of growth.
In value terms, the largest medicaments of alkaloids or derivatives thereof importing markets worldwide were Malaysia ($268M), Japan ($235M) and Australia ($103M), together comprising 36% of global imports. Canada, Lebanon, South Korea, the UK, Iran, Ukraine, Nigeria, Zimbabwe, Kuwait and Democratic Republic of the Congo lagged somewhat behind, together accounting for a further 32%.
In terms of the main importing countries, Lebanon, with a CAGR of +25.9%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other global leaders experienced more modest paces of growth.
Import Prices By Country
In 2022, the average import price for medicaments of alkaloids or derivatives thereof amounted to $53,126 per ton, declining by -3% against the previous year. Overall, the import price continues to indicate a perceptible curtailment. The pace of growth appeared the most rapid in 2018 when the average import price increased by 24% against the previous year. Over the period under review, average import prices attained the peak figure at $92,937 per ton in 2014; however, from 2015 to 2022, import prices remained at a lower figure.
Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Malaysia ($191,791 per ton), while Democratic Republic of the Congo ($3,831 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Malaysia (+13.0%), while the other global leaders experienced more modest paces of growth.
Exports
World Exports of Medicaments Of Alkaloids Or Derivatives Thereof
For the seventh year in a row, the global market recorded decline in shipments abroad of medicaments of alkaloids or derivatives thereof, which decreased by -5.9% to 4.8K tons in 2022. Overall, exports continue to indicate a significant decrease. The most prominent rate of growth was recorded in 2015 when exports increased by 17% against the previous year. The global exports peaked at 53K tons in 2012; however, from 2013 to 2022, the exports stood at a somewhat lower figure.
In value terms, exports of medicaments of alkaloids or derivatives thereof expanded to $143M in 2022. In general, exports continue to indicate a significant decrease. The most prominent rate of growth was recorded in 2015 when exports increased by 62% against the previous year. As a result, the exports reached the peak of $6.1B. From 2016 to 2022, the growth of the global exports of failed to regain momentum.
Exports By Country
Hong Kong SAR represented the largest exporting country with an export of about 2.1K tons, which reached 43% of total exports. New Zealand (667 tons) ranks second in terms of the total exports with a 14% share, followed by Chile (7.7%). Norway (158 tons), Mexico (121 tons), Australia (97 tons), Israel (86 tons), Mauritius (84 tons), Kenya (84 tons), Pakistan (81 tons), North Macedonia (78 tons) and the UK (73 tons) followed a long way behind the leaders.
Exports from Hong Kong SAR decreased at an average annual rate of -7.3% from 2012 to 2022. At the same time, Mauritius (+61.1%), Norway (+58.3%), New Zealand (+23.0%), Pakistan (+15.3%), Kenya (+12.5%), Israel (+8.0%) and North Macedonia (+2.8%) displayed positive paces of growth. Moreover, Mauritius emerged as the fastest-growing exporter exported in the world, with a CAGR of +61.1% from 2012-2022. Chile experienced a relatively flat trend pattern. By contrast, Mexico (-3.7%), Australia (-4.6%) and the UK (-37.0%) illustrated a downward trend over the same period. Hong Kong SAR (+35 p.p.), New Zealand (+14 p.p.), Chile (+7 p.p.), Norway (+3.3 p.p.), Mexico (+2.2 p.p.), Mauritius (+1.7 p.p.), Australia (+1.7 p.p.), Israel (+1.7 p.p.), Kenya (+1.7 p.p.) and Pakistan (+1.6 p.p.) significantly strengthened its position in terms of the global exports, while the UK saw its share reduced by -12.5% from 2012 to 2022, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.
In value terms, Hong Kong SAR ($38M) remains the largest medicaments of alkaloids or derivatives thereof supplier worldwide, comprising 26% of global exports. The second position in the ranking was held by New Zealand ($12M), with an 8.5% share of global exports. It was followed by North Macedonia, with a 7% share.
From 2012 to 2022, the average annual growth rate of value in Hong Kong SAR totaled +3.4%. In the other countries, the average annual rates were as follows: New Zealand (+5.8% per year) and North Macedonia (+11.0% per year).
Export Prices By Country
The average export price for medicaments of alkaloids or derivatives thereof stood at $29,630 per ton in 2022, with an increase of 9.3% against the previous year. Over the period under review, the export price, however, saw a abrupt contraction. The pace of growth appeared the most rapid in 2015 an increase of 38% against the previous year. As a result, the export price attained the peak level of $121,495 per ton. From 2016 to 2022, the average export prices remained at a lower figure.
There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was North Macedonia ($128,810 per ton), while Kenya ($4,043 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Israel (+15.2%), while the other global leaders experienced more modest paces of growth.
This report provides an in-depth analysis of the global market for medicaments of alkaloids or derivatives thereof. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201310 - Medicaments of alkaloids or derivatives thereof, n.p.r.s.
- Prodcom 21201340 - Medicaments of alkaloids or derivatives thereof, p.r.s.
Country coverage:
Worldwide - the report contains statistical data for 200 countries and includes detailed profiles of the 50 largest consuming countries:
- USA
- China
- Japan
- Germany
- United Kingdom
- France
- Brazil
- Italy
- Russian Federation
- India
- Canada
- Australia
- Republic of Korea
- Spain
- Mexico
- Indonesia
- Netherlands
- Turkey
- Saudi Arabia
- Switzerland
- Sweden
- Nigeria
- Poland
- Belgium
- Argentina
- Norway
- Austria
- Thailand
- United Arab Emirates
- Colombia
- Denmark
- South Africa
- Malaysia
- Israel
- Singapore
- Egypt
- Philippines
- Finland
- Chile
- Ireland
- Pakistan
- Greece
- Portugal
- Kazakhstan
- Algeria
- Czech Republic
- Qatar
- Peru
- Romania
- Vietnam
+ the largest producing countries
Data coverage:
- Global market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Global production, split by region and country
- Global trade (exports and imports)
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- CONSUMPTION BY COUNTRY
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. GLOBAL PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- PRODUCTION BY COUNTRY
8. GLOBAL IMPORTS
The Largest Importers on The Market and How They Succeed
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. GLOBAL EXPORTS
The Largest Exporters on The Market and How They Succeed
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- United States
- China
- Japan
- Germany
- United Kingdom
- France
- Brazil
- Italy
- Russian Federation
- India
- Canada
- Australia
- Republic of Korea
- Spain
- Mexico
- Indonesia
- Netherlands
- Turkey
- Saudi Arabia
- Switzerland
- Sweden
- Nigeria
- Poland
- Belgium
- Argentina
- Norway
- Austria
- Thailand
- United Arab Emirates
- Colombia
- Denmark
- South Africa
- Malaysia
- Israel
- Singapore
- Egypt
- Philippines
- Finland
- Chile
- Ireland
- Pakistan
- Greece
- Portugal
- Kazakhstan
- Algeria
- Czech Republic
- Qatar
- Peru
- Romania
- Vietnam
-
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption, By Country, 2018–2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Destination, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Origin, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Consumption, By Country, 2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Production, By Country, 2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, 2012–2023
This report provides an in-depth analysis of the global market for medicaments of alkaloids or derivatives thereof.
This report provides an in-depth analysis of the global medicaments containing hormones market.
This report provides an in-depth analysis of the global medicaments containing insulin market.
This report provides an in-depth analysis of the global medicaments containing penicillin market.
This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.
This report provides an in-depth analysis of the global market for medicaments of other antibiotics.